Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
3FPrQabJ6UzYyFfR